(AGN) Aegon - Ratings and Ratios
Exchange: AS • Country: Netherlands • Currency: EUR • Type: Common Stock • ISIN: NL0000303709
AGN: Insurance, Pensions, Retirement, Annuities, Investments, Mortgages
Aegon NV (AS:AGN) is a Dutch multinational insurance and asset management giant with a rich history dating back to 1844. The company operates across the United States, the Netherlands, the United Kingdom, and other international markets. Its core offerings include life, accident, property and casualty, and health insurance, complemented by annuities, retirement plans, mutual funds, and stable value solutions. Aegon also provides residential mortgage services, digital banking solutions, and a range of investment management products for both retail and institutional clients. The company’s brand portfolio includes Aegon and Transamerica, two well-established names in the financial services industry.
Headquartered in The Hague, Aegon NV is listed on the Euronext Amsterdam stock exchange under the ticker symbol AGN. As of the latest data, the company boasts a market capitalization of 10,324.90 million EUR, reflecting its significant presence in the global insurance and asset management sectors. Aegon’s forward P/E ratio stands at 8.61, while its price-to-book ratio is 1.22, indicating its valuation relative to book value. The price-to-sales ratio of 0.81 provides further insight into its revenue multiples.
Aegon’s financial health and operational efficiency are critical factors for investors and fund managers. The company’s diversified product portfolio and geographic reach provide a balanced risk profile, which is essential for long-term stability. Its focus on digital transformation and customer-centric solutions positions it well in a rapidly evolving financial landscape. For investors seeking exposure to the insurance and asset management sectors, Aegon NV offers a compelling combination of historical resilience and strategic growth initiatives.
Additional Sources for AGN Stock
AGN Stock Overview
Market Cap in USD | 10,666m |
Sector | Financial Services |
Industry | Insurance - Diversified |
GiC Sub-Industry | Multi-line Insurance |
IPO / Inception |
AGN Stock Ratings
Growth 5y | 88.5% |
Fundamental | -15.4% |
Dividend | 92.2% |
Rel. Strength Industry | -7.5 |
Analysts | - |
Fair Price Momentum | 6.53 EUR |
Fair Price DCF | 10.56 EUR |
AGN Dividends
Dividend Yield 12m | 8.84% |
Yield on Cost 5y | 28.02% |
Annual Growth 5y | 39.77% |
Payout Consistency | 82.5% |
AGN Growth Ratios
Growth Correlation 3m | 38.3% |
Growth Correlation 12m | 70.9% |
Growth Correlation 5y | 94.9% |
CAGR 5y | 25.41% |
CAGR/Max DD 5y | 0.80 |
Sharpe Ratio 12m | 1.95 |
Alpha | 1.72 |
Beta | 0.90 |
Volatility | 44.44% |
Current Volume | 7257.7k |
Average Volume 20d | 5763.6k |
As of March 09, 2025, the stock is trading at EUR 5.80 with a total of 7,257,714 shares traded.
Over the past week, the price has changed by -4.45%, over one month by -9.06%, over three months by -5.38% and over the past year by +13.80%.
Neither. Based on ValueRay Fundamental Analyses, Aegon is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -15.36 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AGN as of March 2025 is 6.53. This means that AGN is currently undervalued and has a potential upside of +12.59% (Margin of Safety).
Aegon has no consensus analysts rating.
According to ValueRays Forecast Model, AGN Aegon will be worth about 7.3 in March 2026. The stock is currently trading at 5.80. This means that the stock has a potential upside of +25.69%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 6.8 | 17.4% |
Analysts Target Price | - | - |
ValueRay Target Price | 7.3 | 25.7% |